666

LUSHANG FREDA PHARMACEUTICAL

No trades
See on Supercharts

600223 fundamentals

LUSHANG FREDA PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 600223 for the last quarter is 881.28 M CNY, and it's 24.78% lower compared to the previous quarter. The net income of Q1 24 is 59.04 M CNY.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth